Review of a tumor target used for scans and targeted radiation
Original title: Somatostatin Receptor Expression and Theranostic Applications Across Non-Neuroendocrine Tumors: A Molecular-to-Clinical Review.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This looks across many earlier studies rather than running a new one.
This is a review of where the science is heading, not a treatment you can get.
The short version
Some tumors, including meningioma, carry a target that special scans and radiation drugs can find.
What was studied. This review looked at past published studies, not new patients. It covered brain and spine tumors, head and neck, thyroid, lung, breast, lymphoma, and melanoma.
What they found. Meningioma showed strong amounts of this target on the tumor cells. One type of nasopharyngeal cancer and some breast cancers did too. In other cancers the target sat mostly on nearby support cells, and scan results varied.
What this means, and what it doesn't
What it could mean: Early reports suggest this targeted radiation may help some people with these tumors. Scans might one day help doctors pick who could benefit. For now, that choice is not settled.
What it doesn't mean: This is a summary of where the science stands, not a new result. The authors say the evidence is limited and mostly looks backward. This treatment is not proven or standard care for these tumors, and it is not a cure.
Source: PubMed, September 28, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.